At the interface of technology and biological discovery, we develop tools to model, probe, and interface with human tissues, harness them towards accelerating the development of disease-modifying therapeutic interventions, and deploy them across disease areas driven by clinical impact, particularly for neurological disease.  

​​

We are located in the Center for Genomic Medicine in Massachusetts General Hospital, at the convergence of scientific discovery and clinical insights. We collaborate with scientists, engineers, clinicians, and industry partners towards accelerating impactful innovation.​